Stocks / CCCC
Stock profile · 銘柄

C4 Therapeutics, Inc. - Common Stock (CCCC)

C4 Therapeutics, Inc. - Common Stock (CCCC) last closed at $4.67 (as of 2026-06-30). On Shishin's four-engine momentum model it scored 36/100, flagged by the Suzaku engine on its most recent scan appearance (2026-06-29). It has surfaced in 1 daily scan since 2026-06-29. The figures below are research data, the composite score and the momentum, trend, and volatility indicators the engines observe, not investment advice.

Price updates daily; the engine read reflects CCCC's most recent scan appearance. Shishin's live daily signals are published each morning on the rankings board.

Composite score36
Active engineSuzaku
SetupOTHER
Current close$4.67
SectorBiotechnology
Price · last ~60 sessions
$4.263/94/206/30
Indicators · as of 2026-06-29
ADR · 20d10.1%
ATR · 148.1%
RSI · 1461
Return · 30d+16%
Return · 60d+62%
Above MA205%
Above MA5022%
Range · 20d34%
MA stack3
From 52w high-7%
$ Vol · 30d$9M
Vol ratio2.36×
Frequently asked

What is CCCC's Shishin momentum score?

As of 2026-06-29, CCCC scores 36/100 on Shishin's four-engine composite, flagged by the Suzaku engine. The score blends momentum, trend, and volatility indicators on a 0 to 100 scale.

Is CCCC showing a momentum setup?

CCCC's current setup state is "OTHER." This describes what the engines observe in the chart structure, it is a data classification, not a recommendation to buy or sell.

Which Shishin engine flags CCCC?

Most recently the Suzaku engine. Each of the four guardians is tuned for a different market regime.

How often has CCCC appeared in Shishin scans?

CCCC has appeared in 1 daily scan since 2026-06-29. Recurring appearances indicate a persistent setup; one-off appearances are more transient.

How is the Shishin score calculated?

The composite is a weighted blend of momentum (multi-horizon returns), trend (moving-average stack, distance from MAs), and volatility/liquidity (ADR, ATR, dollar volume) indicators, scored per the engine active for the current market regime.

Related reading

Research data, not investment advice. Shishin publishes what its systematic engines observe; it does not recommend buying or selling any security, and is not a registered investment adviser or broker-dealer. See our risk disclosure.

Today's full rankings →5-year track record →More Biotechnology momentum stocks →More Suzaku setups →All covered stocks →